Giuseppe Curigliano
MD, PhD
Head, Division of Early Drug Development
👥Biography 个人简介
Giuseppe Curigliano has led international efforts to define de-escalation strategies in HER2-positive and hormone receptor-positive breast cancer, including co-authoring ESMO guidelines. He directs early drug development at the European Institute of Oncology. His work has shaped global standards for tailored breast cancer therapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Giuseppe Curigliano 的研究动态
Follow Giuseppe Curigliano's research updates
留下邮箱，当我们发布与 Giuseppe Curigliano（European Institute of Oncology (IEO), University of Milan）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment